Medical Technology Industry in
Epalinges
35 companies in Medical Technology Industry based in Epalinges — name and year of registration from the commercial register. The list below shows them all.
All 35 companies in Epalinges
Distalmotion SA
Since 2012 · 101–500 empl.5.0(3)
The core activity of Distalmotion is the development and provision of solutions for robotic surgery, particularly in the field of minimally invasive surgical care. The company aims to make the benefits of robotic surgery accessible to more surgeons, hospitals and patients worldwide.
Adipogen SA
Since 2009 · 11–20 empl.
Adipogen SA supplies research reagents and assay kits for life‑science research, including antibodies, recombinant proteins, ELISA kits, biochemicals and small molecules. The company also provides technical support and services for research customers.
Remora Biotech SA
Since 2009 · 11–20 empl.
The core activity of Infinite Vision Optics SAS is the development and manufacture of innovative intraocular lenses for the treatment of cataracts, particularly the PreciSight product, which enables an exchangeable front lens to achieve the best possible visual acuity for the patient.
Gondola Medical Technologies SA
Since 2011 · 11–20 empl.
The core activity of Gondola Medical Technologies is the development and distribution of medical technologies, in particular the Gondola AMPS, a clinically tested therapy for the treatment of gait and balance disorders caused by neurological diseases.
Novassay SA
Since 2013 · 11–20 empl.
The core activity of CentOS is the development and provision of a stable, predictable, manageable and reproducible Linux distribution based on the sources of Red Hat Enterprise Linux (RHEL).
Novigenix SA
Since 2014 · 21–50 empl.
The core activity of Novigenix is the development and application of precision medicine solutions, particularly in the field of cancer early detection and treatment, using liquid biopsy technologies and artificial intelligence (AI) based analysis platforms, such as the LITOSeek platform. The company focuses on researching and developing innovative approaches to cancer treatment, including the identification of new target molecules for drugs and the development of precision medicine approaches for personalized cancer treatment.
Vitruvian Shield SA
Since 2016 · 21–50 empl.
The core activity of Vitruvian Shield is the development and provision of solutions for telemedicine and wearable medical devices, including an API platform, portable devices and mobile apps.
SeedIMPULSE SA
Since 2017 · 1–10 empl.
The core activity of SeedIMPULSE is the development and distribution of medical software, in particular the EZplan software platform, which supports orthopedic surgeons in planning joint replacement operations (hip, knee and shoulder). The software enables efficient planning of operations based on 3D images and soon also 2D X-ray images, and allows the ideal implant to be selected from a wide range of options.
Novostia SA
Since 2017 · 11–20 empl.
The core activity of Novostia is the development and manufacture of medical devices, particularly heart valves, as well as the conduct of clinical trials and the obtaining of approvals (CE marking, FDA clearance) for these products.
Volumina Medical SA
Since 2018 · 11–20 empl.
The core activity of Volumina Medical is the development and marketing of innovative biomaterials for regenerative medicine, particularly for the reconstruction of soft tissue in plastic surgery and aesthetic medicine. The company focuses on the development of minimally invasive solutions based on research results from the Swiss Federal Institute of Technology Lausanne (EPFL).
Arga Medtech SA
Since 2020 · 11–20 empl.
The core activity of Argá Medtech SA is the development and marketing of medical devices, particularly in the fields of cardiology and neuromodulation. The company focuses on the development of innovative technologies, such as Sine-Wave technology for pulsed field cardiac ablation, and offers solutions for the treatment of arrhythmias and other cardiological diseases.
ORYL Photonics SA
Since 2020 · 11–20 empl.
The core activity of Oryl Photonics is the development and manufacturing of laboratory instruments based on proprietary light scattering technology, particularly for measuring the solubility of substances in pharmaceuticals and materials science.
Hedera Dx SA
Since 2021 · 11–20 empl.
The core activity of Hedera Dx is the development and provision of liquid biopsy solutions for oncology, specifically NGS-based (Next-Generation Sequencing) solutions that can be processed in-house. The company aims to become a global provider of analytically and clinically validated liquid biopsy tests that are used in daily practice and comply with guidelines and regulatory-approved cancer treatment options.
Impli SA
Since 2022 · 11–20 empl.
The core activity of Impli is the development and provision of a real-time hormone monitoring system for assisted reproduction, particularly for in-vitro fertilization (IVF). The system aims to enable real-time monitoring of women's hormone levels to increase the chances of successful fertilization and pregnancy.
GetSet Surgical SA
Since 2016 · 1–10 empl.
GetSet Surgical SA develops and supplies sterile, ready-to-use implants and instrument sets for spinal surgery, marketed under the "Good to Go!" product line. The company offers sterile-packed implants and streamlined instrument sets designed to reduce handling, simplify pre-operative preparation and support on-demand procedures.
ASPIVIX SA
Since 2015 · 11–20 empl.5.0(1)
The core activity of Aspivix is the development and manufacture of medical devices, particularly in the field of gynecology, with the goal of improving women's healthcare. Specifically, the company focuses on developing products such as Carevix, a cervical stabilizer with suction, which enables doctors to have a transparent and open conversation with their patients about cervical stabilization.
LifeDX SA
Since 2023 · 11–20 empl.
The core activity of LifeDX SA is the development and manufacture of rapid diagnostic tests and devices for healthcare, particularly for the early detection and diagnosis of diseases such as HIV, syphilis, hepatitis, COVID-19, influenza, and malaria. The company focuses on creating accessible and cost-effective solutions for healthcare in developing and middle-income countries.
Abionic SA
Since 2010 · 21–50 empl.3.7(3)
The core activity of Abionic is the development and manufacture of medical diagnostic devices, in particular the near-patient rapid diagnostic platform abioSCOPE, which delivers lab-quality results from a drop of blood within minutes. The focus is on the early detection and diagnosis of sepsis and other diseases in emergency departments and intensive care units.
PeriVision SA
Since 2022 · 11–20 empl.5.0(1)
The core activity of PeriVision SA is the development and provision of solutions for ophthalmology, particularly in the area of patient monitoring and the improvement of treatment for eye diseases through the use of artificial intelligence (AI) and at-home vision tests.
Evidone SA
Since 2024 · 1–10 empl.
Evidone SA develops AI- and sensor-based solutions that monitor surgical instruments, staff and intraoperative workflows to improve operating room efficiency and operational reliability.
Novigenix AI SA
Since 2025 · 1–10 empl.
Novigenix AI SA develops liquid biopsy and multi-omics solutions based on the LITOSeek™ platform for immuno-transcriptomics analysis. The company uses AI and RNA data to discover biomarkers, predict therapy response, and support the development of cancer treatments.
MoleSense Sàrl
Since 2025 · 1–10 empl.
MoleSense Sàrl develops a molecular wearable for maternity health monitoring before, during and after pregnancy. The company measures hormonal and inflammatory biomarkers non-invasively through sweat analysis to track biological changes over time.
Synameta Therapeutics SARL
Since 2025 · 1–10 empl.
Synameta Therapeutics SARL develops an exosome-based platform for targeted therapeutic delivery. The company works on virus-free biovectors for applications in oncology and gene therapy.
Dexterous Endoscopes Sàrl
Since 2026 · 1–10 empl.
Dexterous Endoscopes Sàrl develops variable-stiffness endoscopes for minimally invasive procedures, with a focus on ENT applications such as sinus and larynx surgery. The company is working on a controllable-stiffness technology designed to improve control and precision in hard-to-reach anatomical areas.
Pilatus Biosciences SA
Since 2022 · 1–10 empl.
SerTeQua D. Buffat
Since 2025 · 1–10 empl.
GenArt - Michel Bonzon
Since 2008 · 1–10 empl.
Testmate Health SA
Since 2020 · 1–10 empl.
Emovo Care SA
Since 2020 · 1–10 empl.
Precisia Care SA
Since 2023 · 1–10 empl.
MedPrecis SA
Since 2023 · 1–10 empl.
Undae Science SA
Since 2024 · 1–10 empl.
VITRUVIAN SHIELD HOLDING SA
Since 2025 · 1–10 empl.
K-S Medical Technologies SARL
Since 2025 · 1–10 empl.
Circum Jewel Dial SA
Since 2025 · 1–10 empl.
Medical Technology Industry in Epalinges
Medical Technology Industry in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 11, 2026
Medical Technology Industry in other places
By canton